Paolo Lusso
#160,759
Most Influential Person Now
Researcher
Paolo Lusso's AcademicInfluence.com Rankings
Paolo Lussophysics Degrees
Physics
#7381
World Rank
#9409
Historical Rank
Cosmology
#245
World Rank
#256
Historical Rank
Astrophysics
#618
World Rank
#666
Historical Rank

Download Badge
Physics
Paolo Lusso's Degrees
- PhD Physics University of Milan
- Masters Physics University of Milan
- Bachelors Physics University of Milan
Why Is Paolo Lusso Influential?
(Suggest an Edit or Addition)Paolo Lusso's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells (1995) (2825)
- Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. (1995) (911)
- In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression (1997) (692)
- The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection (1996) (533)
- CD46 Is a Cellular Receptor for Human Herpesvirus 6 (1999) (523)
- Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6 (1989) (324)
- In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6) (1988) (322)
- Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. (1995) (309)
- Chromosomally integrated human herpesvirus 6: questions and answers (2011) (306)
- Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1 (1995) (281)
- Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6 (1991) (271)
- Classification of HHV-6A and HHV-6B as distinct viruses (2014) (266)
- Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization (1994) (260)
- HIV and the chemokine system: 10 years later (2006) (230)
- Infection of natural killer cells by human herpesvirus 6 (1993) (212)
- Human herpes virus‐6 increases HIV‐1 expression in co‐infected T cells via nuclear factors binding to the HIV‐1 enhancer. (1989) (211)
- CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. (1994) (198)
- Viral DNA carried by human immunodeficiency virus type 1 virions (1992) (198)
- Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses (2000) (190)
- Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes (2003) (177)
- C–C Chemokines Released by Lipopolysaccharide (LPS)-stimulated Human Macrophages Suppress HIV-1 Infection in Both Macrophages and T Cells (1997) (176)
- Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. (2005) (169)
- Human B-lymphotropic virus (human herpesvirus-6). (1988) (162)
- Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. (1998) (151)
- A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load (2008) (151)
- HBLV (orHHV-6) in human cell lines (1987) (149)
- Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. (1990) (148)
- Real-Time Quantitative PCR for Human Herpesvirus 6 DNA (2000) (142)
- CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. (1998) (138)
- Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele (1997) (138)
- Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. (1991) (134)
- Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6) (1988) (130)
- Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. (1993) (127)
- International Network for Comparison of HIV Neutralization Assays: The NeutNet Report (2009) (124)
- Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. (1999) (114)
- Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6 (2001) (114)
- Selective suppression of IL-12 production by human herpesvirus 6. (2003) (112)
- Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. (2007) (112)
- Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells. (1994) (112)
- Human herpesvirus 6 in AIDS. (1995) (111)
- Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection (1995) (107)
- Glycosylation, hypogammaglobulinemia, and resistance to viral infections. (2014) (107)
- HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis (2013) (104)
- Clinical significance of HIV-1 coreceptor usage (2011) (103)
- Rapid Diagnosis of Mycobacterial Infections and Quantitation of Mycobacterium tuberculosis Load by Two Real-Time Calibrated PCR Assays (2003) (102)
- In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity. (1988) (101)
- Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages (1993) (99)
- HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. (2006) (99)
- HBLV (or HHV-6) in human cell lines. (1987) (97)
- Pathogenic Effects of Human Herpesvirus 6 in Human Lymphoid Tissue Ex Vivo (2003) (97)
- Cryptic Nature of a Conserved, CD4-Inducible V3 Loop Neutralization Epitope in the Native Envelope Glycoprotein Oligomer of CCR5-Restricted, but Not CXCR4-Using, Primary Human Immunodeficiency Virus Type 1 Strains (2005) (96)
- Recognition of RANTES by extracellular parts of the CCR5 receptor. (2007) (95)
- Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression (1994) (93)
- Role of β-Chemokines in Suppressing HIV Replication (1996) (93)
- Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements (1993) (91)
- Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans (1997) (89)
- Disseminated human herpesvirus 6 infection In AIDS (1993) (88)
- Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor (2012) (82)
- Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer (2017) (82)
- Quantitative PCR for human herpesviruses 6 and 7 (1995) (82)
- IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. (2012) (79)
- Human herpesvirus 6A accelerates AIDS progression in macaques (2007) (77)
- Interaction of Glycoprotein H of Human Herpesvirus 6 with the Cellular Receptor CD46* (2003) (76)
- Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. (1990) (74)
- Human herpesvirus 6 in AIDS (1994) (73)
- Viral Replication-Independent Blockade of Dendritic Cell Maturation and Interleukin-12 Production by Human Herpesvirus 6 (2005) (70)
- Different stages of B cell differentiation in non-T acute lymphoblastic leukemia. (1984) (69)
- Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function* (2002) (69)
- Pregnancy outcome in patients with pityriasis rosea. (2008) (67)
- Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection. (1999) (66)
- Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1. (1988) (65)
- DIVERSE TROPISM OF HUMAN B-LYMPHOTROPIC VIRUS (HUMAN HERPESVIRUS 6) (1987) (63)
- Engineering of Lactobacillus jensenii To Secrete RANTES and a CCR5 Antagonist Analogue as Live HIV-1 Blockers (2010) (63)
- Chemokines and viruses: the dearest enemies. (2000) (61)
- Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer (2011) (60)
- Chemokines as natural HIV antagonists. (2002) (60)
- CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses (1990) (60)
- Expression of CD4 on human peripheral blood neutrophils. (2003) (58)
- Viral Interactions in Human Lymphoid Tissue: Human Herpesvirus 7 Suppresses the Replication of CCR5-Tropic Human Immunodeficiency Virus Type 1 via CD4 Modulation (2006) (58)
- Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals (2007) (57)
- Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. (1993) (56)
- Human Herpesvirus 6 (HHV-6) Causes Severe Thymocyte Depletion in SCID-hu Thy/Liv Mice (1999) (55)
- Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein. (2008) (54)
- Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases (2013) (54)
- Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES (2001) (53)
- Calibrated Real-Time PCR Assay for Quantitation of Human Herpesvirus 8 DNA in Biological Fluids (2002) (52)
- Discrepancy between phenotypic and functional features of natural killer T‐lymphocytes in B‐cell chronic lymphocytic leukaemia (1984) (52)
- Detection of human herpesvirus 6 and human papillomavirus 16 in cervical carcinoma. (1994) (50)
- Enhancement of the HIV‐1 inhibitory activity of RANTES by modification of the N‐terminal region: dissociation from CCR5 activation (2000) (50)
- In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo (1990) (49)
- Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma. (1999) (48)
- CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV–1 strains in a T–cell line (1995) (47)
- Rational design of novel HIV-1 entry inhibitors by RANTES engineering. (2008) (46)
- Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization. (1996) (45)
- Immunomodulation and immunosuppression by human herpesvirus 6A and 6B. (2013) (45)
- Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing (2017) (44)
- Immature T lymphocytes in human cord blood identified by monoclonal antibodies: a model for the study of the differentiation pathway of T cells in humans. (1984) (43)
- Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects (1990) (42)
- Biological and molecular characteristics of human herpesvirus 7: in vitro growth optimization and development of a syncytia inhibition test. (1994) (41)
- Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases. (2009) (40)
- Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages (2013) (40)
- A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques (2021) (40)
- CD4 IS NOT THE MEMBRANE RECEPTOR FOR HHV-6 (1989) (40)
- Inhibition of HIV-1 Infection by Human α-Defensin-5, a Natural Antimicrobial Peptide Expressed in the Genital and Intestinal Mucosae (2012) (39)
- Increased proportion of suppressor/cytotoxic (OKT8+) cells in patients with Hodgkin's disease in long‐lasting remission (1983) (39)
- Interference between human herpesvirus 7 and HIV-1 in mononuclear phagocytes. (1996) (38)
- Human herpesvirus 6 (HHV-6). (1996) (37)
- Inhibition of CXCR4-Tropic HIV-1 Infection by Lipopolysaccharide: Evidence of Different Mechanisms in Macrophages and T Lymphocytes1 (2002) (37)
- Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer. (2018) (35)
- HIV and chemokines: implications for therapy and vaccine. (2002) (35)
- Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population (1985) (33)
- The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 (2013) (33)
- Effect of reciprocal complementation of two defective human immunodeficiency virus type 1 (HIV-1) molecular clones on HIV-1 cell tropism and virulence (1992) (32)
- Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals (2002) (32)
- Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120. (1995) (32)
- Treatment with IL-7 Prevents the Decline of Circulating CD4+ T Cells during the Acute Phase of SIV Infection in Rhesus Macaques (2012) (31)
- Reduced natural killer T‐cells in B‐cell chronic lymphocytic leukaemia identified by three monoclonal antibodies: Leu‐11, A10, AB8.28 (1986) (31)
- Development of Reverse Transcriptase PCR Assays for Detection of Active Human Herpesvirus 6 Infection (2001) (31)
- Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples. (2013) (30)
- Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2–V3 interaction and modulates neutralization sensitivity (2014) (30)
- Differential Responses of Plasmacytoid Dendritic Cells to Influenza Virus and Distinct Viral Pathogens (2014) (30)
- Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection. (1997) (27)
- Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies. (2003) (27)
- A relapsing inflammatory syndrome and active human herpesvirus 8 infection. (2005) (27)
- In vitro susceptibility of Macaca nemestrina to human herpesvirus 6: a potential animal model of coinfection with primate immunodeficiency viruses. (1994) (26)
- Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A (2009) (26)
- Development of a Human Herpesvirus 6 Species-Specific Immunoblotting Assay (2012) (24)
- Effect of alpha-interferon on the immune system of patients with hairy cell leukemia. (1987) (24)
- Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation. (2015) (23)
- Nonrandom TRGγ variable gene rearrangement in normal human T cells and T cell leukemias (1988) (23)
- Improvement of antibody functionality by structure-guided paratope engraftment (2019) (23)
- Human herpesvirus type 7 in Hodgkin's disease (1998) (23)
- The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT (2008) (22)
- Molecular engineering of RANTES peptide mimetics with potent anti‐HIV‐1 activity (2011) (22)
- 3' c-myc rearrangement in a human leukemic T-cell line. (1986) (22)
- HHV-6 and CMV pneumonitis in immunocompromised patients (1994) (21)
- Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population. (1985) (20)
- Differentiated human neural stem cells: a new ex vivo model to study HHV-6 infection of the central nervous system. (2006) (20)
- Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma (2018) (20)
- Human herpesvirus 6. (1995) (20)
- HHV-8 DNA replication correlates with the clinical status in AIDS-related Kaposi's sarcoma. (2016) (20)
- Coinfection of SCID-hu Thy/Liv Mice with Human Herpesvirus 6 and Human Immunodeficiency Virus Type 1 (2000) (19)
- Pathogenesis of AIDS. (1992) (19)
- Molecular and immunological evidence of B‐cell commitment in “null” acute lymphoblastic leukaemia (1986) (18)
- Recent developments in animal models for human herpesvirus 6A and 6B. (2014) (17)
- Productive infection of HUVEC by HHV-8 is associated with changes compatible with angiogenic transformations. (2009) (17)
- Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2). (1987) (16)
- HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions. (2020) (15)
- Enhancement of TAT‐induced transactivation of the HIV‐1 LTR by two genomic fragments of HHV‐6 (1996) (15)
- A novel leukemia T-cell line (PF-382) with phenotypic and functional features of suppressor lymphocytes. (1985) (15)
- The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants. (2009) (15)
- Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. (2002) (14)
- A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2. (2011) (14)
- Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small‐ and large‐scale Miltenyi cell sorting system (2002) (14)
- Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity. (2006) (14)
- Diverse tropism of HBLV (human herpesvirus 6) (1987) (12)
- Structural Determinants for the Selective Anti-HIV-1 Activity of the All-β Alternative Conformer of XCL1 (2015) (12)
- CHEMOKINES AND HIV INFECTION (1997) (12)
- Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides. (2012) (12)
- HHV-6B infection, T-cell reconstitution, and graft-vs-host disease after hematopoietic stem cell transplantation (2018) (12)
- Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages. (2009) (12)
- Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation (2018) (12)
- Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classification. (1987) (12)
- Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry (2016) (12)
- Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia. (1986) (12)
- Morphological and ultrastructural changes induced in corneal epithelial cells by HIV-1 and HHV-6 in vitro. (1996) (11)
- Chemokine receptors as new molecular targets for antiviral therapy. (2004) (11)
- Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). (1989) (11)
- Protein-based HIV-1 microbicides. (2014) (10)
- Immunological dysregulation of lymph nodes in AIDS patients. (1991) (10)
- Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability (2012) (10)
- Viral DNA Carried byHumanImmunodeficiency Virus Type1Virions (1992) (9)
- Reaction Patterns of the Lymph Node (1991) (9)
- Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees (2020) (9)
- Response: Role of β-Chemokines in Suppressing HIV Replication (1996) (9)
- Release of interleukin-2-like material by B-chronic lymphocytic leukemia cells. An autocrine or paracrine model of production and utilization? (1988) (9)
- Multistage carcinogenesis utilizing human genital cells and human papillomaviruses. (1994) (9)
- Analysis of serum and plasma beta chemokines in primary HIV infection (PHI). (2000) (8)
- Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants (2022) (8)
- Chronic T-cell leukaemias. III. T-colonies, PHA response and correlation with membrane phenotype. (1982) (8)
- C-C chemokine RANTES and HIV long terminal repeat-driven gene expression. (1997) (8)
- Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection (2009) (7)
- Design of HIV Coreceptor Derived Peptides That Inhibit Viral Entry at Submicromolar Concentrations. (2017) (7)
- Calibration Technologies for Correct Determination of Epstein-Barr Virus, Human Herpesvirus 6 (HHV-6), and HHV-8 Antiviral Drug Susceptibilities by Use of Real-Time-PCR-Based Assays (2013) (7)
- Functional Anatomy of the Trimer Apex Reveals Key Hydrophobic Constraints That Maintain the HIV-1 Envelope Spike in a Closed State (2021) (7)
- A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses. (2012) (7)
- Nef-specific CD45RA+ CD8+ T cells secreting MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection (2010) (7)
- Picking the lock with a hairpin. Did HIV-1 learn the art from chemokines? (2003) (6)
- Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody Directed against a gp120-Induced Epitope of CD4 (2011) (6)
- Chemokines and HIV: The First Close Encounter (2015) (6)
- Normal T-Lymphocyte Function in Patients with Hodgkin's Disease in Long-Lasting Remission (1986) (5)
- Relevance of monoclonal antibodies in the diagnosis of unusual T-cell acute lymphoblastic leukaemia. (2009) (5)
- Virus-encoded chemokines, chemokine receptors and chemokine-binding proteins: new paradigms for future therapy (2007) (5)
- CD8+ T lymphocyte-derived chemokines and other HIV-suppressive factors: mini-review. (1998) (5)
- Proliferative T‐Cell Response to HIV Envelope Glycoprotein in Immunized and Infected Primates and Human Beings (1989) (5)
- Integrin α4β7 in HIV‐1 infection: A critical review (2020) (5)
- Corrigendum: Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer (2017) (4)
- Interaction of HBLV (HHV-6) With EBV and HIV (1989) (4)
- A human leukemic T cell line (PF-382) inhibits the growth of myeloid and erythroid progenitor cells. (1987) (4)
- A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention (2021) (4)
- A chemokine trap for HIV co-receptors (1997) (4)
- Unsung Hero Robert C. Gallo (2009) (4)
- Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys (2022) (4)
- Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1. (1989) (4)
- New EMBO Member's Review HIV and the chemokine system: 10 years later (2006) (3)
- Anti-PF4 antibodies associated with disease severity in COVID-19 (2022) (3)
- Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains (2015) (3)
- Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement (2021) (3)
- Nonrandom TRG gamma variable gene rearrangement in normal human T cells and T cell leukemias. (1988) (3)
- P-D3 Structural determinants for the selective Anti-HIV-1 activity of the all-beta alternative conformer of XCL1 (2016) (3)
- Chapter 3 Target cells for infection (1992) (3)
- P-D4 Tyrosine-sulfated peptides from the gp120 V2 domain block HIV-1 entry through CCR5 Mimicry (2016) (3)
- Effects of 12-o-tetradecanoyl-phorbol-13-acetate (TPA) on the colony growth of human T lymphocytes. (1984) (3)
- Accelerated progression to AIDS in macaques coinfected with simian immunodeficiency virus and human herpesvirus 6A (2006) (3)
- Response: Role of beta-Chemokines in Suppressing HIV Replication. (1996) (3)
- Normal helper T-cell function in hairy-cell leukaemia. (2009) (3)
- HHV-6 and HIV-1 Infection (2006) (2)
- P-selectin glycoprotein ligand-1 (PSGL-1/CD162) is incorporated into clinical HIV-1 isolates and can mediate virus capture and subsequent transfer to permissive cells (2022) (2)
- Biological Features of HHV-6 (2006) (2)
- INTERACTIONS BETWEEN HHV-6 AND HIV: HHV-6 AS A POTENTIAL COFACTOR IN AIDS (1994) (2)
- Multi-step purification strategy for RANTES wild-type and mutated analogues expressed in a baculovirus system. (2000) (2)
- Quaternary Interaction of the HIV-1 Envelope Trimer with CD4 and Neutralizing Antibodies (2021) (2)
- Chapter 10 Interactions between HHV-6 and other viruses (1992) (2)
- Epidemiology of infection with HIV-1 in Sardinia: A multicentre prospective study (2006) (1)
- Possibility that transmissible viruses might be involved in the etiology of human cancer. (2003) (1)
- 107 Interleukin-7 as an Immune Reconstitution Agent in HIV-1 Infection: Ex Vivo and In Vivo Protective Effects on CD4+ T Cells (2012) (1)
- High prevalence of human herpes virus 6 DNA in Hodgkin's disease: a study by in situ hybridization and polymerase chain reaction (1995) (1)
- Design of RANTES-derived Peptides With Enhanced HIV-inhibitory Activity and Derivation of Resistant HIV-1 Strains (2005) (1)
- Immunological and Molecular Classification of Human Leukemias (1986) (1)
- The P-selectin ligand PSGL-1 (CD162) is efficiently incorporated by primary HIV-1 isolates and can facilitate trans-infection (2021) (1)
- P-C21 Molecular Mimicry of a Helical Region in Domain 1 of CD4 Facilitates Interdomain Stabilization of HIV-1 gp120 (2017) (1)
- 73: Human herpesvirus 6 and multiple sclerosis: detection by quantitative real-time PCR and role of complement-mediated damage secondary to CD46 inactivation (2006) (1)
- Standardization of HIV Neutralization Assays for Use in Vaccine Research and Clinical Trials: Results from the NeutNet Working Group (2008) (1)
- UvA-DARE (Digital Academic Repository) Clinical significance of HIV-1 coreceptor usage (1)
- Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants (2022) (1)
- Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4 pos (2013) (1)
- Prolonged asymptomatic HIV-1 infection. (2000) (1)
- Considerations on human Herpesvirus 6 reactivation after cord blood transplantation (2018) (1)
- Human herpesvirus-6 may be a cofactor in AIDS. (1991) (1)
- Chemokines and Chemokine Receptors in HIV Infection (2003) (1)
- I-101 Quaternary contact improves the potency of broadly neutralizing antibodies to the CD4-binding site of HIV-1 (2019) (0)
- Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains (2015) (0)
- Chromosomally int 6 : questions and an Reviews in Medical Virology (2011) (0)
- P-D6 Structure-Function Relationships in the Second Variable Domain (V2) of HIV-1 gp120 (2014) (0)
- Macrophages by CXCR4-Dependent Primary Coreceptor for Infection of Human Cutting Edge: CXCR4 Is a Functional (2013) (0)
- MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection (2010) (0)
- RANTES mutants and therapeutic uses thereof (1998) (0)
- Fighting HIV: a little help from Toxoplasma ? (2003) (0)
- 7q-and loss of a polymorphism for the met oncogene in a patient with myelofibrosis (1987) (0)
- Improvement of antibody functionality by structure-guided paratope engraftment (2019) (0)
- of nucleic acid quantification method. (1998) (0)
- P-D5 Two conserved tyrosines in the HIV-1 envelope V2 loop play a critical role in gp120/gp41 association (2016) (0)
- in Non-T Acute Lymphoblastic Leukemia (1984) (0)
- Conformational Changes in HIV-1 Env Trimer Induced by a Single CD4 as Revealed by Cryo-EM (2017) (0)
- The quest for an HIV-1 vaccine: will mRNA deliver us from evil? (2023) (0)
- P-D14 Increasing the Level of Tyrosine Sulfation Alters the Antigenic Profile of the BG505 SOSIP.664 Trimer (2014) (0)
- A Structure-Based Matrix Approach Yields Improved VRC01-Class Antibodies for HIV-1 Therapy and Prevention (2020) (0)
- Classification of HHV-6A and HHV-6B as distinct viruses (2013) (0)
- Suppression of Primate Immunodeficiency Lentiretroviruses by CD8+ T-Cell-Derived Soluble Factors (2000) (0)
- Translocation of the c-myc oncogene 3′ to the immunoglobin heavy chain enhancer in the tumor DNA from a Burkitt lymphoma (1986) (0)
- HIV Research in the SCID Mouse: Biosafety Considerations (2005) (0)
- HHV-6 and CMV pneumonitis in immunocompromised patients. (1994) (0)
- A method for quantitative detection of nucleic acids (1999) (0)
- Chapter 17 – Human Herpesvirus 6 (1999) (0)
- IL4 HHV-6 AND THE IMMUNE SYSTEM (2007) (0)
- Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques (2022) (0)
- Role of HIV-1 TAT gene product and of cytokines released by activated immune cells in the pathogenesis of AIDS-associated Kaposi’s sarcoma. (1991) (0)
- ResearchNef-specific CD 45 RA + CD 8 + T cells secreting MIP-1 β but not IFN-γ are associated with nonprogressive HIV-1 infection (2015) (0)
- In Reply: Pseudotypes in HIV-Infected Mice. (1990) (0)
- Mutants rantes et leurs applications therapeutiques (1998) (0)
- Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters (2022) (0)
- Distribution of HHV-8 in blood cells of Kaposi's sarcoma patients: Evidence for HHV-8 infection of CD34+ cells (1998) (0)
- B-111 Sulfotyrosine-mediated V2-V3 interaction stabilizes the HIV-1 envelope trimer facilitating immune evasion (2016) (0)
- Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4posT cells and macrophages (2013) (0)
- Cervical Carcinoma (2020) (0)
- 18: Quantitation of viral DNA in biological fluids: from the bench to the bedside (2006) (0)
- released IL 2 is absorbed by the neoplastic B cell population from patients with B-chronic lymphocytic leukemia: evidence that normally Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes (2013) (0)
- D-106 Tyrosine Sulfation in the Second Variable Domain (V2) of gp120 Regulates HIV-1 Sensitivity to Neutralization (2014) (0)
- Lymphocytes Mechanisms in Macrophages and T by Lipopolysaccharide : Evidence of Different Inhibition of CXCR 4-Tropic HIV-1 Infection (2002) (0)
- P-D4 Inhibition of HIV-1 by the C-chemokine XCL1/Lymphotactin is dependent on high affinity binding to glycosaminoglycans (GAG) (2014) (0)
- Chronic T‐cell leukaemias. A variant of T‐prolymphocytic leukaemias: morphological, immunological and clinical characterization of 2 cases (1987) (0)
- Cc chemokine that prevent infection with viruses reto (1996) (0)
- [OK T-positivity in stimulated T-lymphocytes]. (1982) (0)
- Intracellular immunization against HIV-1 by poly-TAR RNA elements (1991) (0)
- Milestones: Dr. Robert C. Gallo and the Discovery of HIV-1 (2023) (0)
- B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes (1989) (0)
- F-103 Structure–Function Elucidation of the Native HIV-1 Envelope Trimer As a Basis for Rational Vaccine Design (2017) (0)
- RANTES mutants and their therapeutic applications (1998) (0)
- Persistent Infection ofRhesusMacaques witha Molecular Cloneof HumanImmunodeficiency VirusType2:Evidence ofMinimal Genetic Drift andLowPathogenetic Effects (1990) (0)
- Cytopathic Infection Of Natural Killer (nk) Cells By Hiv-6: Induction Of Cd4 And Susceptibility To Hiv-1 Infection (1993) (0)
- 139 Epitope Masking Mechanism Within the HIV-1 Env Trimer Analyzed by Functional Subunit Complementation (2012) (0)
- [Effect of human plasma on the in vitro formation of T-lymphocyte colonies]. (1982) (0)
- P-C6 tyrosine-sulfated peptides from the V2 loop of gp120 Are potent HIV-1 inhibitors (2017) (0)
- P-selectin glycoprotein ligand-1 (PSGL-1/CD162) is incorporated into clinical HIV-1 isolates and can mediate virus capture and subsequent transfer to permissive cells (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paolo Lusso?
Paolo Lusso is affiliated with the following schools: